Quick Answer
Matinas BioPharma Holdings, Inc. reported Total Assets of $7.21 million for the year ending 2025.
- Matinas BioPharma Holdings, Inc. showed a decrease of -43.0% in Total Assets from 2024 to 2025.
- This data is from Matinas BioPharma Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $7.36 million | Q3 2014: $5.79 million | Q1 2015: $9.80 million | Q2 2015: $11.86 million | Q3 2015: $9.87 million | Q1 2016: $6.75 million | Q2 2016: $5.56 million | Q3 2016: $11.31 million | Q1 2017: $22.03 million | Q2 2017: $17.80 million | Q3 2017: $16.52 million | Q1 2018: $11.49 million | Q2 2018: $16.04 million | Q3 2018: $14.41 million | Q1 2019: $50.57 million | Q2 2019: $48.21 million | Q3 2019: $44.82 million | Q1 2020: $84.11 million | Q2 2020: $79.09 million | Q3 2020: $74.81 million | Q1 2021: $72.35 million | Q2 2021: $69.97 million | Q3 2021: $66.98 million | Q1 2022: $55.78 million | Q2 2022: $52.42 million | Q3 2022: $47.55 million | Q1 2023: $38.26 million | Q2 2023: $34.03 million | Q3 2023: $29.79 million | Q1 2024: $19.61 million | Q2 2024: $24.37 million | Q3 2024: $20.58 million | Q1 2025: $12.04 million | Q2 2025: $11.42 million | Q3 2025: $9.70 million.
- Over the full 13 years of available data (2013 to 2025), Matinas BioPharma Holdings, Inc.'s Total Assets has declined by 36.4%.
- Historical annual values: Fiscal year 2025: $7.21 million | Fiscal year 2024: $12.64 million | Fiscal year 2023: $25.10 million | Fiscal year 2022: $44.82 million | Fiscal year 2021: $61.33 million | Fiscal year 2020: $70.97 million | Fiscal year 2019: $40.24 million | Fiscal year 2018: $19.94 million | Fiscal year 2017: $14.42 million | Fiscal year 2016: $9.82 million | Fiscal year 2015: $8.41 million | Fiscal year 2014: $3.36 million | Fiscal year 2013: $11.33 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: